Moderna Inc

NASDAQ:MRNA  
149.98
+7.13 (+4.99%)
5:10:32 PM EDT: $150.13 +0.15 (+0.10%)
Products

FDA Authorizes Moderna And Pfizer-Biontech Covid-19 Vaccines For Children Down To 6 Months Of Age

Published: 06/17/2022 17:59 GMT
Moderna Inc (MRNA) - FDA Authorizes Moderna and Pfizer-biontech Covid-19 Vaccines for Children Down to 6 Months of Age.
FDA - for the Pfizer-biontech Covid-19 Vaccine, the FDA Amended the Eua to Include Use of the Vaccine in Individuals 6 Months Through 4 Years of Age.
FDA - for Moderna Covid-19 Vaccine, Amended Eua to Include Use of the Vaccine in Individuals 6 Months Through 17 Years of Age.
FDA - the Moderna Covid-19 Vaccine is Administered As a Primary Series of Two Doses, One Month Apart, to Individuals 6 Months Through 17 Years of Age.
FDA - Pfizer-biontech Covid-19 Vaccine is Administered As a Primary Series of Three Doses.
Further Company Coverage: [22uay.
De].
((reuters.
Briefs@thomsonreuters.
Com;)).